feverfew: mechanisms of action and clinical efficacy for migraines and arthritis ·  ·...

8
Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis Randomised Double-Blind Placebo-Controlled Trial of Feverfew in Migraine Prevention Efficacy of Feverfew as Prophylactic Treatment of Migraine The Therapeutic Activity of Feverfew on Migraines and Epilepsy May be Due to Its GABA-Benzodiaepine Modulatory Eſtects.-Green Med Info Summary The Efficacy and Safety of Feverfew (Tanacetum Pahenium L.): An Update of a Systematic Review Gene Responses of Human Momocytic Cells for the Detection of Anti- migraine Activity of Fever Extracts Appllcatlon of NFkappaB Inhibitor for Ahritis Inhibition of 5-Lipoxygenase and Cyclo-Oxygena in Leukocytes by Feverfew. Involvement of Sesquiterpene Lactones and Other Components

Upload: others

Post on 30-May-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis ·  · 2017-10-16Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis

Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis

• Randomised Double-Blind Placebo-Controlled Trial of Feverfew in MigrainePrevention

• Efficacy of Feverfew as Prophylactic Treatment of Migraine

• The Therapeutic Activity of Feverfew on Migraines and Epilepsy May be Dueto Its GABA-Benzodiaepine Modulatory Eftects.-Green Med Info Summary

• The Efficacy and Safety of Feverfew (Tanacetum Parthenium L.): An Updateof a Systematic Review

• Gene Responses of Human Momocytic Cells for the Detection of Anti­migraine Activity of Fever Extracts

• Appllcatlon of NFkappaB Inhibitor for Arthritis

• Inhibition of 5-Lipoxygenase and Cyclo-Oxygenase in Leukocytes byFeverfew. Involvement of Sesquiterpene Lactones and Other Components

Page 2: Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis ·  · 2017-10-16Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis
Page 3: Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis ·  · 2017-10-16Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis
Page 4: Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis ·  · 2017-10-16Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis
Page 5: Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis ·  · 2017-10-16Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis
Page 6: Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis ·  · 2017-10-16Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis
Page 7: Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis ·  · 2017-10-16Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis
Page 8: Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis ·  · 2017-10-16Feverfew: Mechanisms of Action and Clinical Efficacy for Migraines and Arthritis